You are here

Article Text

Article menu
Download PDFPDF
Evolution of Neisseria gonorrhoeae drug susceptibility in Buenos Aires, Argentina, 1985–99
  1. Angela Famiglietti1,
  2. S D Garcia1,
  3. C A de Mier1,
  4. R Casco2,
  5. L Belli2,
  6. F Marcenac3,
  7. C Vay3,
  8. R A de Torres4
  1. 1Clinical Microbiology Division, Department of Clinical Biochemistry, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Argentina
  2. 2STD Service, Faculty of Medicine, Hospital Nacional de Clínicas José de San Martín, Universidad de Buenos Aires
  3. 3Clinical Microbiology Division, Department of Clinical Chemistry, Faculty of Pharmacy and Biochemistry, University of Buenos Aires
  4. 4Faculty of Pharmacy and Biochemistry, University of Buenos Aires
  1. Dr R A de Torres, 1113 Ciudad de Buenos Aires, Facultad de Farmacia y Bioquimica, Junin 956 4 Piso, Argentina detorres{at}ffyb.uba.ar

https://doi.org/10.1136/sti.77.2.142

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Demographic data

    Buenos Aires (Argentina) is an international port city of three million people surrounded by greater Buenos Aires, with a core population of 10 million people.

    The STD service of the Hospital Nacional de Cllínicas, University of Buenos Aires (HNC) deals with 80% patients from the city and 20% from the suburban areas. A total of 33 316 symptomatic patients (27 458 men and 5858 women) were studied from 1985–99.1 Patients attended under the standard regulations of HNC primary care protocol, and so no additional written informed consent was required.

    Methods

    Neisseria gonorrhoeae (NG) was investigated by direct Gram stain microscopy and by culture in Columbia agar supplemented with 5% blood and …

    View Full Text